Trace Amine-Associated Receptors as Emerging Therapeutic Targets

AUTOR(ES)

Sotnikova, Tatyana D.

FONTE

American Society for Pharmacology and Experimental Therapeutics

RESUMO

Endogenous trace amines (TAs) of unknown biological function are structurally related to classic monoaminergic neurotransmitters and found at low concentrations in the mammalian brain. Their recently discovered group of G protein-coupled receptors, trace amine-associated receptors (TAARs), may represent putative targets not only for trace and other amines but also for a variety of monoaminergic compounds, including amphetamines and monoamine metabolites. The trace amine-associated receptor 1 (TAAR1), which is in part associated with the monoaminergic neuronal circuitry controlling various functions, including movement, is the best characterized of the class, although little is known about its regulation and function. Here we review the pharmacology and biochemical properties of the TAAR1 and its physiological functions as revealed in studies involving knockout mice lacking this receptor. Potential therapeutic applications of future selective TAAR1 agonists and antagonists are also discussed. Although understanding of biology and functions mediated by other TAARs is still in its infancy, it is expected that further characterization of the functional roles and biochemical properties of TAARs and identification of endogenous and exogenous ligands will eventually promote these receptors as an attractive class of targets to correct monoaminergic processes that could be dysfunctional in a host of disorders of brain and periphery.

Documentos Relacionados

• Imidazoline binding sites on receptors and enzymes: Emerging targets for novel antidepressant drugs?
• Prospects for atherosclerosis regression through increase in high‐density lipoprotein and other emerging therapeutic targets
• Endothelin receptors as novel targets in tumor therapy
• Trypanosoma cruzi-elicited CD8+ T cell-mediated myocarditis: chemokine receptors and adhesion molecules as potential therapeutic targets to control chronic inflammation?
• Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer